JCARE Stock Overview
Joincare Pharmaceutical Group Industry Co.,Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
No risks detected for JCARE from our risk checks.
Joincare Pharmaceutical Group Industry Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥8.00 |
| 52 Week High | CN¥0 |
| 52 Week Low | CN¥0 |
| Beta | 0.44 |
| 11 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 0% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -44.06% |
Recent News & Updates
Recent updates
Shareholder Returns
| JCARE | CH Pharmaceuticals | CH Market | |
|---|---|---|---|
| 7D | 0% | -3.0% | -1.4% |
| 1Y | 0% | 7.1% | 4.8% |
Return vs Industry: JCARE underperformed the Swiss Pharmaceuticals industry which returned 7.1% over the past year.
Return vs Market: JCARE underperformed the Swiss Market which returned 4.8% over the past year.
Price Volatility
| JCARE volatility | |
|---|---|
| JCARE Average Weekly Movement | 0% |
| Pharmaceuticals Industry Average Movement | 2.9% |
| Market Average Movement | 3.3% |
| 10% most volatile stocks in CH Market | 6.5% |
| 10% least volatile stocks in CH Market | 1.6% |
Stable Share Price: Data is not available.
Volatility Over Time: Insufficient data to determine JCARE's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 14,365 | Xiong Yu | www.joincare.com |
Joincare Pharmaceutical Group Industry Co.,Ltd. engages in the research, development, production, and sale of pharmaceuticals and health care products primarily in China. The company offers chemical preparation for drugs, including digestive tract, cardiovascular and cerebrovascular, antimicrobial, anti-tumor, assisted reproductive, neurological therapeutic, OCT, and other drugs; and traditional Chinese drug preparation production, which includes anti-tumor and cold products.
Joincare Pharmaceutical Group Industry Co.,Ltd. Fundamentals Summary
| JCARE fundamental statistics | |
|---|---|
| Market cap | US$3.03b |
| Earnings (TTM) | US$203.20m |
| Revenue (TTM) | US$2.20b |
14.9x
P/E Ratio1.4x
P/S RatioIs JCARE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| JCARE income statement (TTM) | |
|---|---|
| Revenue | CN¥15.89b |
| Cost of Revenue | CN¥6.16b |
| Gross Profit | CN¥9.73b |
| Other Expenses | CN¥8.26b |
| Earnings | CN¥1.47b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Nov 25, 2024
| Earnings per share (EPS) | 0.78 |
| Gross Margin | 61.21% |
| Net Profit Margin | 9.25% |
| Debt/Equity Ratio | 22.7% |
How did JCARE perform over the long term?
See historical performance and comparison